Gene · 5214
Papers1,761
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,761
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PFKP silencing suppresses tumor growth via the AXL-MET axis. | Int J Biol Sci | 2024 | 39664584 | PubTator, text mining | PubMed |
| Screening of hub genes for sepsis-induced myopathy by weighted gene co-expression network analysis and protein-protein interaction network construction. | BMC Musculoskelet Disord | 2024 | 39438952 | PubTator, text mining | PubMed |
| PLOD1 promote proliferation and migration with glycolysis via the Wnt/β-catenin pathway in THCA. | Genomics | 2024 | 39424162 | PubTator, text mining | PubMed |
| Exploring a new signature for lung adenocarcinoma: analyzing cuproptosis-related genes through Integrated single-cell and bulk RNA sequencing. | Discov Oncol | 2024 | 39342548 | PubTator, text mining | PubMed |
| Trim21 mediates metabolic reprogramming in renal tubular cells via PFKP ubiquitination to alleviate renal fibrosis. | J Cell Physiol | 2024 | 39308018 | PubTator, text mining | PubMed |
| Suppression of ZEB1 by Ethyl caffeate attenuates renal fibrosis via switching glycolytic reprogramming. | Pharmacol Res | 2024 | 39270946 | PubTator, text mining | PubMed |
| A comprehensive prognostic and immunological implications of PFKP in pan-cancer. | Cancer Cell Int | 2024 | 39252014 | PubTator, text mining | PubMed |
| A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression. | Mol Cancer | 2024 | 38982480 | PubTator, text mining | PubMed |
| Quercetin alleviates liver fibrosis via regulating glycolysis of liver sinusoidal endothelial cells and neutrophil infiltration. | Biomol Biomed | 2024 | 38943679 | PubTator, text mining | PubMed |
| YTHDF2 regulates MSS51 expression contributing to mitochondria dysfunction of granulosa cells in polycystic ovarian syndrome patients. | Mol Cell Endocrinol | 2024 | 38830447 | PubTator, text mining | PubMed |
| Lactylome analyses suggest systematic lysine-lactylated substrates in oral squamous cell carcinoma under normoxia and hypoxia. | Cell Signal | 2024 | 38750680 | PubTator, text mining | PubMed |
| Changes in the Transcription of Proliferation- and Apoptosis-Related Genes in Embryos in Women of Different Ages under the Influence of Extracellular Vesicles from Donor Follicular Fluid In Vitro. | Bull Exp Biol Med | 2024 | 38727955 | PubTator, text mining | PubMed |
| Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism. | Int J Mol Sci | 2024 | 38673877 | PubTator, text mining | PubMed |
| IL-6-Driven Autocrine Lactate Promotes Immune Escape of Uveal Melanoma. | Invest Ophthalmol Vis Sci | 2024 | 38551584 | PubTator, text mining | PubMed |
| When the Embryo Meets the Endometrium: Identifying the Features Required for Successful Embryo Implantation. | Int J Mol Sci | 2024 | 38474081 | PubTator, text mining | PubMed |
| Identification and Analysis of Gene Biomarkers for Ovarian Cancer. | Genet Test Mol Biomarkers | 2024 | 38416665 | PubTator, text mining | PubMed |
| Epigenetic-related transcriptional reprogramming elucidated by identification and validation of a novel reference gene combination for RT-qPCR studies in porcine oocytes of contrasting quality. | Mol Biol Rep | 2024 | 38411699 | PubTator, text mining | PubMed |
| HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. | Sci Adv | 2024 | 38394204 | PubTator, text mining | PubMed |
| SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming. | Nat Cell Biol | 2024 | 38321204 | PubTator, text mining | PubMed |
| Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains. | Acta Neuropathol | 2024 | 38308693 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5214/papers?page=7